Clinical benefit and tolerability of CDK4/6 inhibitors in the treatment of breast cancer advanced in the geriatric population – real life data from a Hospital Center. (November 2022) - Costa, M.; Valente, A.C.; Freitas, M.; Almeida, C.; Teixeira, C.; Gonçalves, M.; Tavares, N.; Almeida, D.; Caeiro, C.; Augusto, I.; Sousa, I.; Barbosa, M.